To identify synthetically lethal vulnerabilities of GATA3 in breast cancer, we analyzed the breast cancer cell line (n = 22, Supplementary Data 1) data from the large-scale, deep RNAi screen project DRIVE15 using our recently developed SLIdR algorithm18. This evidence concerns the gene GATA3 and breast cancer.